Purification and Characterization of Tumor Hemolytic Factor from Cancer Cells
Author Information
Author(s): S. Zucker, J. Wieman, R.M. Lysik, B. Imhof, A.A. Farooqui
Primary Institution: Veterans Administration Medical Center, Northport, New York and State University of New York at Stony Brook, Stony Brook, New York, and Ohio State University, Columbus, Ohio
Hypothesis
The study aims to purify and characterize the soluble tumor hemolytic factor (sTHF) produced by oncogene transformed fibroblasts.
Conclusion
The study successfully purified a soluble tumor hemolytic factor from transformed fibroblasts, which has a molecular weight of approximately 66,000 Da.
Supporting Evidence
- Transformed fibroblasts released a soluble tumor hemolytic factor that was purified over 3,000-fold.
- SDS-PAGE showed a single protein band of 66,000 Da for the soluble tumor hemolytic factor.
- The hemolytic factor was found to be metal-dependent and heat-labile.
Takeaway
Researchers found a special protein in cancer cells that can break down red blood cells, which might help us understand how cancer affects the body.
Methodology
Transformed fibroblasts were cultivated in serum-free medium, and the soluble tumor hemolytic factor was purified using ammonium sulfate precipitation and various chromatography techniques.
Limitations
The pathophysiological role of sTHF in cancer remains to be determined.
Want to read the original?
Access the complete publication on the publisher's website